Licensed Practical Nurse in Snow Hill, MD Accepting Medicare
4 Licensed Practical Nurse nurses found. Showing 1 - 4
 Annemarie Shipley, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 6040 Public Landing Rd, Snow Hill, MD 21863 Phone: 410-632-1100 |
 Robert Coleman Godbout, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 6040 Public Landing Rd, Snow Hill, MD 21863 Phone: 410-632-1100 |
Jaime Faye Thomas, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 6040 Public Landing Rd, Snow Hill, MD 21863 Phone: 410-632-1100 Fax: 410-632-2476 |
Janna D Landon Butler, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 6040 Public Landing Rd, Snow Hill, MD 21863 Phone: 410-632-1100 |
News Archive
APP Pharmaceutical continues support of FDA's USP standards for unfractionated heparin
APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., (NASDAQ:APCVZ), and the leading supplier of heparin sodium to the U.S. market, announced today its continued support of the US Food & Drug Administration (FDA) and medical community for the October 1, 2009 implementation of the new United States Pharmacopeia (USP) monograph change for unfractionated heparin.
Scientists look to create blood platelets from stem cells to study genetics of blood clotting disorders
Johns Hopkins scientists have launched a pioneering research program to create, for the first time, human platelet cells from stem cells in order to study inherited blood clotting abnormalities ranging from clots that cause heart attacks and stroke to bleeding disorders. The study is funded by a $9 million grant from the National Institutes of Health (NIH) as part of a nationwide initiative to examine how genetic variations cause heart, lung and blood diseases.
Notch protein helps human embryonic stem cells 'decide' their own fate
Researchers at Johns Hopkins have discovered that the Notch protein helps human embryonic stem cells 'decide' their own fate, a finding which may eventually be useful in programming cells for the development of stem cell therapies. Their results are reported in the May 2008 issue of Cell Stem Cell.
New data on Phase 3 SIMPONI clinical trials for rheumatoid arthritis
New long-term data from two pivotal, Phase 3 clinical trials showed that patients with active rheumatoid arthritis (RA) receiving SIMPONI(TM) (golimumab) every four weeks achieved sustained improvements in signs and symptoms and physical function response through one year. These new data were presented today at the 2009 American College of Rheumatology (ACR) Annual Scientific Meeting.
› Verified 5 days ago
Registered Nurse
Licensed Practical Nurse
Nurse Practitioner
Advanced Practice Midwife